High-fat diet-induced obesity and insulin resistance in CYP4A14–/– mice is mediated by 20-HETE

Ankit Gilani, Varunkumar Pandey, Victor Garcia, Kevin Agostinucci, Shailendra P. Singh, Joseph Schragenheim, Lars Bellner, J R Falck, Mahesh P. Paudyal, Jorge H. Capdevila, Nader G. Abraham, Michal Laniado Schwartzman

Research output: Contribution to journalArticle

Abstract

20-Hydroxyeicosatetraenoic acid (20-HETE) has been shown to positively correlate with body mass index, hyperglycemia, and plasma insulin levels. This study seeks to identify a causal relationship between 20-HETE and obesity-driven insulin resistance. Cyp4a14–/– male mice, a model of 20-HETE overproduction, were fed a regular or high-fat diet (HFD) for 15 wk. 20-SOLA [2,5,8, 11,14,17-hexaoxanonadecan-19-yl 20-hydroxyeicosa-6(Z),15(Z)-dienoate], a 20-HETE antagonist, was administered from week 0 or week 7 of HFD. HFD-fed mice gained significant weight (16.7 ± 3.2 vs. 3.8 ± 0.35 g, P < 0.05) and developed hyperglycemia (157 ± 3 vs. 121 ± 7 mg/dl, P < 0.05) and hyperinsulinemia (2.3 ± 0.4 vs. 0.5 ± 0.1 ng/ml, P < 0.05) compared with regular diet-fed mice. 20-SOLA attenuated HFD-induced weight gain (9.4 ± 1 vs. 16.7 ± 3g, P < 0.05) and normalized the hyperglycemia (157 ± 7 vs. 102 ± 5 mg/dl, P < 0.05) and hyperinsulinemia (1.1 ± 0.1 vs. 2.3 ± 0.4 ng/ml, P < 0.05). The impaired glucose homeostasis and insulin resistance in HFD-fed mice evidenced by reduced insulin and glucose tolerance were also ameliorated by 20-SOLA. Circulatory and adipose tissue 20-HETE levels significantly increased in HFD-fed mice correlating with impaired insulin signaling, including reduction in insulin receptor tyrosine (Y972) phosphorylation and increased serine (S307) phosphorylation of the insulin receptor substrate-1 (IRS-1). 20-SOLA treatments prevented changes in insulin signaling. These findings indicate that 20-HETE contributes to HFD-induced obesity, insulin resistance, and impaired insulin signaling.

Original languageEnglish (US)
Pages (from-to)R934-R944
JournalAmerican Journal of Physiology - Regulatory Integrative and Comparative Physiology
Volume315
Issue number5
DOIs
StatePublished - Nov 1 2018

Fingerprint

High Fat Diet
Insulin Resistance
Obesity
Insulin
Hyperglycemia
Hyperinsulinism
Phosphorylation
Insulin Receptor Substrate Proteins
Glucose
Insulin Receptor
20-hydroxy-5,8,11,14-eicosatetraenoic acid
Serine
Weight Gain
Tyrosine
Adipose Tissue
Body Mass Index
Homeostasis
Diet
Weights and Measures

Keywords

  • Hyperglycemia
  • Hyperinsulinemia
  • Insulin resistance
  • Obesity

ASJC Scopus subject areas

  • Physiology
  • Physiology (medical)

Cite this

High-fat diet-induced obesity and insulin resistance in CYP4A14–/– mice is mediated by 20-HETE. / Gilani, Ankit; Pandey, Varunkumar; Garcia, Victor; Agostinucci, Kevin; Singh, Shailendra P.; Schragenheim, Joseph; Bellner, Lars; Falck, J R; Paudyal, Mahesh P.; Capdevila, Jorge H.; Abraham, Nader G.; Laniado Schwartzman, Michal.

In: American Journal of Physiology - Regulatory Integrative and Comparative Physiology, Vol. 315, No. 5, 01.11.2018, p. R934-R944.

Research output: Contribution to journalArticle

Gilani, A, Pandey, V, Garcia, V, Agostinucci, K, Singh, SP, Schragenheim, J, Bellner, L, Falck, JR, Paudyal, MP, Capdevila, JH, Abraham, NG & Laniado Schwartzman, M 2018, 'High-fat diet-induced obesity and insulin resistance in CYP4A14–/– mice is mediated by 20-HETE', American Journal of Physiology - Regulatory Integrative and Comparative Physiology, vol. 315, no. 5, pp. R934-R944. https://doi.org/10.1152/ajpregu.00125.2018
Gilani, Ankit ; Pandey, Varunkumar ; Garcia, Victor ; Agostinucci, Kevin ; Singh, Shailendra P. ; Schragenheim, Joseph ; Bellner, Lars ; Falck, J R ; Paudyal, Mahesh P. ; Capdevila, Jorge H. ; Abraham, Nader G. ; Laniado Schwartzman, Michal. / High-fat diet-induced obesity and insulin resistance in CYP4A14–/– mice is mediated by 20-HETE. In: American Journal of Physiology - Regulatory Integrative and Comparative Physiology. 2018 ; Vol. 315, No. 5. pp. R934-R944.
@article{0e4aa739d5994b38860b3a4a03362d8f,
title = "High-fat diet-induced obesity and insulin resistance in CYP4A14–/– mice is mediated by 20-HETE",
abstract = "20-Hydroxyeicosatetraenoic acid (20-HETE) has been shown to positively correlate with body mass index, hyperglycemia, and plasma insulin levels. This study seeks to identify a causal relationship between 20-HETE and obesity-driven insulin resistance. Cyp4a14–/– male mice, a model of 20-HETE overproduction, were fed a regular or high-fat diet (HFD) for 15 wk. 20-SOLA [2,5,8, 11,14,17-hexaoxanonadecan-19-yl 20-hydroxyeicosa-6(Z),15(Z)-dienoate], a 20-HETE antagonist, was administered from week 0 or week 7 of HFD. HFD-fed mice gained significant weight (16.7 ± 3.2 vs. 3.8 ± 0.35 g, P < 0.05) and developed hyperglycemia (157 ± 3 vs. 121 ± 7 mg/dl, P < 0.05) and hyperinsulinemia (2.3 ± 0.4 vs. 0.5 ± 0.1 ng/ml, P < 0.05) compared with regular diet-fed mice. 20-SOLA attenuated HFD-induced weight gain (9.4 ± 1 vs. 16.7 ± 3g, P < 0.05) and normalized the hyperglycemia (157 ± 7 vs. 102 ± 5 mg/dl, P < 0.05) and hyperinsulinemia (1.1 ± 0.1 vs. 2.3 ± 0.4 ng/ml, P < 0.05). The impaired glucose homeostasis and insulin resistance in HFD-fed mice evidenced by reduced insulin and glucose tolerance were also ameliorated by 20-SOLA. Circulatory and adipose tissue 20-HETE levels significantly increased in HFD-fed mice correlating with impaired insulin signaling, including reduction in insulin receptor tyrosine (Y972) phosphorylation and increased serine (S307) phosphorylation of the insulin receptor substrate-1 (IRS-1). 20-SOLA treatments prevented changes in insulin signaling. These findings indicate that 20-HETE contributes to HFD-induced obesity, insulin resistance, and impaired insulin signaling.",
keywords = "Hyperglycemia, Hyperinsulinemia, Insulin resistance, Obesity",
author = "Ankit Gilani and Varunkumar Pandey and Victor Garcia and Kevin Agostinucci and Singh, {Shailendra P.} and Joseph Schragenheim and Lars Bellner and Falck, {J R} and Paudyal, {Mahesh P.} and Capdevila, {Jorge H.} and Abraham, {Nader G.} and {Laniado Schwartzman}, Michal",
year = "2018",
month = "11",
day = "1",
doi = "10.1152/ajpregu.00125.2018",
language = "English (US)",
volume = "315",
pages = "R934--R944",
journal = "American Journal of Physiology - Heart and Circulatory Physiology",
issn = "0363-6135",
publisher = "American Physiological Society",
number = "5",

}

TY - JOUR

T1 - High-fat diet-induced obesity and insulin resistance in CYP4A14–/– mice is mediated by 20-HETE

AU - Gilani, Ankit

AU - Pandey, Varunkumar

AU - Garcia, Victor

AU - Agostinucci, Kevin

AU - Singh, Shailendra P.

AU - Schragenheim, Joseph

AU - Bellner, Lars

AU - Falck, J R

AU - Paudyal, Mahesh P.

AU - Capdevila, Jorge H.

AU - Abraham, Nader G.

AU - Laniado Schwartzman, Michal

PY - 2018/11/1

Y1 - 2018/11/1

N2 - 20-Hydroxyeicosatetraenoic acid (20-HETE) has been shown to positively correlate with body mass index, hyperglycemia, and plasma insulin levels. This study seeks to identify a causal relationship between 20-HETE and obesity-driven insulin resistance. Cyp4a14–/– male mice, a model of 20-HETE overproduction, were fed a regular or high-fat diet (HFD) for 15 wk. 20-SOLA [2,5,8, 11,14,17-hexaoxanonadecan-19-yl 20-hydroxyeicosa-6(Z),15(Z)-dienoate], a 20-HETE antagonist, was administered from week 0 or week 7 of HFD. HFD-fed mice gained significant weight (16.7 ± 3.2 vs. 3.8 ± 0.35 g, P < 0.05) and developed hyperglycemia (157 ± 3 vs. 121 ± 7 mg/dl, P < 0.05) and hyperinsulinemia (2.3 ± 0.4 vs. 0.5 ± 0.1 ng/ml, P < 0.05) compared with regular diet-fed mice. 20-SOLA attenuated HFD-induced weight gain (9.4 ± 1 vs. 16.7 ± 3g, P < 0.05) and normalized the hyperglycemia (157 ± 7 vs. 102 ± 5 mg/dl, P < 0.05) and hyperinsulinemia (1.1 ± 0.1 vs. 2.3 ± 0.4 ng/ml, P < 0.05). The impaired glucose homeostasis and insulin resistance in HFD-fed mice evidenced by reduced insulin and glucose tolerance were also ameliorated by 20-SOLA. Circulatory and adipose tissue 20-HETE levels significantly increased in HFD-fed mice correlating with impaired insulin signaling, including reduction in insulin receptor tyrosine (Y972) phosphorylation and increased serine (S307) phosphorylation of the insulin receptor substrate-1 (IRS-1). 20-SOLA treatments prevented changes in insulin signaling. These findings indicate that 20-HETE contributes to HFD-induced obesity, insulin resistance, and impaired insulin signaling.

AB - 20-Hydroxyeicosatetraenoic acid (20-HETE) has been shown to positively correlate with body mass index, hyperglycemia, and plasma insulin levels. This study seeks to identify a causal relationship between 20-HETE and obesity-driven insulin resistance. Cyp4a14–/– male mice, a model of 20-HETE overproduction, were fed a regular or high-fat diet (HFD) for 15 wk. 20-SOLA [2,5,8, 11,14,17-hexaoxanonadecan-19-yl 20-hydroxyeicosa-6(Z),15(Z)-dienoate], a 20-HETE antagonist, was administered from week 0 or week 7 of HFD. HFD-fed mice gained significant weight (16.7 ± 3.2 vs. 3.8 ± 0.35 g, P < 0.05) and developed hyperglycemia (157 ± 3 vs. 121 ± 7 mg/dl, P < 0.05) and hyperinsulinemia (2.3 ± 0.4 vs. 0.5 ± 0.1 ng/ml, P < 0.05) compared with regular diet-fed mice. 20-SOLA attenuated HFD-induced weight gain (9.4 ± 1 vs. 16.7 ± 3g, P < 0.05) and normalized the hyperglycemia (157 ± 7 vs. 102 ± 5 mg/dl, P < 0.05) and hyperinsulinemia (1.1 ± 0.1 vs. 2.3 ± 0.4 ng/ml, P < 0.05). The impaired glucose homeostasis and insulin resistance in HFD-fed mice evidenced by reduced insulin and glucose tolerance were also ameliorated by 20-SOLA. Circulatory and adipose tissue 20-HETE levels significantly increased in HFD-fed mice correlating with impaired insulin signaling, including reduction in insulin receptor tyrosine (Y972) phosphorylation and increased serine (S307) phosphorylation of the insulin receptor substrate-1 (IRS-1). 20-SOLA treatments prevented changes in insulin signaling. These findings indicate that 20-HETE contributes to HFD-induced obesity, insulin resistance, and impaired insulin signaling.

KW - Hyperglycemia

KW - Hyperinsulinemia

KW - Insulin resistance

KW - Obesity

UR - http://www.scopus.com/inward/record.url?scp=85055971898&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85055971898&partnerID=8YFLogxK

U2 - 10.1152/ajpregu.00125.2018

DO - 10.1152/ajpregu.00125.2018

M3 - Article

VL - 315

SP - R934-R944

JO - American Journal of Physiology - Heart and Circulatory Physiology

JF - American Journal of Physiology - Heart and Circulatory Physiology

SN - 0363-6135

IS - 5

ER -